PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 214 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $72,000 | +94.6% | 33,578 | +471.4% | 0.01% | 0.0% |
| Q2 2015 | $37,000 | -47.1% | 5,876 | -41.4% | 0.01% | -58.8% |
| Q1 2015 | $70,000 | +18.6% | 10,022 | +29.1% | 0.02% | -10.5% |
| Q4 2014 | $59,000 | -82.1% | 7,760 | -82.4% | 0.02% | -57.8% |
| Q3 2014 | $329,000 | +78.8% | 44,098 | +130.9% | 0.04% | +55.2% |
| Q2 2014 | $184,000 | – | 19,098 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |